Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency.
Frank Cichocki, Heinrich Schlums, Hongchuan Li, Vanessa Stache, Timothy Holmes, Todd R Lenvik, Samuel C C Chiang, Jeffrey S Miller, Marie Meeths, Stephen K Anderson, Yenan T Bryceson
文献索引:J. Exp. Med. 211(6) , 1079-91, (2014)
全文:HTML全文
摘要
Autosomal recessive mutations in UNC13D, the gene that encodes Munc13-4, are associated with familial hemophagocytic lymphohistiocytosis type 3 (FHL3). Munc13-4 expression is obligatory for exocytosis of lytic granules, facilitating cytotoxicity by T cells and natural killer (NK) cells. The mechanisms regulating Munc13-4 expression are unknown. Here, we report that Munc13-4 is highly expressed in differentiated human NK cells and effector CD8(+) T lymphocytes. A UNC13D c.118-308C>T mutation, causative of FHL3, disrupted binding of the ETS family member ELF1 to a conserved intronic sequence. This mutation impairs UNC13D intron 1 recruitment of STAT4 and the chromatin remodeling complex component BRG1, diminishing active histone modifications at the locus. The intronic sequence acted as an overall enhancer of Munc13-4 expression in cytotoxic lymphocytes in addition to representing an alternative promoter encoding a novel Munc13-4 isoform. Mechanistically, T cell receptor engagement facilitated STAT4-dependent Munc13-4 expression in naive CD8(+) T lymphocytes. Collectively, our data demonstrates how chromatin remodeling within an evolutionarily conserved regulatory element in intron 1 of UNC13D regulates the induction of Munc13-4 expression in cytotoxic lymphocytes and suggests that an alternative Munc13-4 isoform is required for lymphocyte cytotoxicity. Thus, mutations associated with primary immunodeficiencies may cause disease by disrupting transcription factor binding. © 2014 Cichocki et al.
相关化合物
相关文献:
2014-08-01
[Mol. Plant 7(8) , 1365-83, (2014)]
2012-07-01
[Int. J. Obes. 38(12) , 1538-44, (2014)]
2014-01-01
[PLoS Biol. 12(1) , e1001758, (2014)]
2014-12-11
[Oncogene 33(50) , 5688-96, (2014)]
2015-04-21
[Proc. Natl. Acad. Sci. U. S. A. 112(16) , 4964-9, (2015)]